| NETRF TAKES TO THE INTERNATIONAL STAGE
NETRF played a meaningful and visible role at the 14th Annual European Neuroendocrine Tumor Society (ENETS) Conference, March 8-10, 2017, in Barcelona, Spain. Our U.S. contingent participated at the podium, in panels, and focused discussions on strengthening ties worldwide in the search for scientific advances in NETs. (MORE)
| |
| PATIENT VOICES AT ENETS For the first time, the International Neuroendocrine Cancer Alliance (INCA), a global voice in support of neuroendocrine cancer patients, played a role in the 14th Annual European Neuroendocrine Tumor Society (ENETS) Conference. A joint INCA/ENETS symposium was held on the final day of the ENETS Conference to prioritize and address unmet needs. (MORE)
| |
| OPPOSITION GROWS TO PROPOSED NIH CUTS Advocates rally for federal funding of cancer researchThe White House released a 2018 budget outline in mid-March that cuts National Institutes of Health (NIH) spending by nearly 20 percent. NETRF shares the concern expressed by other cancer-related organizations and our collaborators that a funding decrease of this magnitude could disrupt, even derail, America’s cancer investigators and research institutions. (MORE)
| |
| INSPIRED BY YOUR EXPERIENCE A NETRF staff profile
The NETRF staff is small, but mighty, dedicated to overcoming a tenacious opponent—neuroendocrine cancers. Toward that noble mission, Laran Hyder, associate director of development and outreach, adeptly juggles a wide range of responsibilities with enthusiasm, passion, and purpose. And her inspiration comes from the patients, families, and researchers she interacts with every day. (MORE)
| |
|
NETRF RECOGNIZED AS TOP-TIER CHARITY
NETRF’s strong financial position, transparency, and accountability again earned it a 4-star rating by Charity Navigator, a national evaluator of nonprofits. The 4-star rating indicates the utmost in fiscal responsibility, ethical practices, and governance. (MORE)
| |
|
CYCLING EVENT RAISES $100K
Congratulations to Cycle for Survival Team NET NYC and Boston, led by Dave McCoy, on their amazing fundraising efforts to support the work of Dr. Diane Reidy-Lagunes! To date, Team NET has nearly raised $100,000 to support Dr. Reidy-Lagunes' research. Using laboratory models, Dr. Reidy-Lagunes and her team are evaluating innovative imaging and targeted-therapy approaches—ultimately leading to a better, more personalized way of managing these difficult-to-treat pancreatic neuroendocrine tumors.
| |
| FREE
PATIENT, FAMILY MEMBER EDUCATION
Learn about the latest treatments for NETs, ask questions of foremost NET experts, and connect with fellow patients, and caregivers at the 6th Annual Focus on Neuroendocrine Tumors on the campus of the University of Pennsylvania, Philadelphia PA, from 8:00 am – 2:30 pm on Friday, May 5, 2017. (MORE)
| | | |
| LEARN ANYTIME, ANYWHERE NET experts at a screen near you
View short videos of our superb patient and family educational conference in February at Stanford University. Talks feature internationally recognized experts from the Sixth Annual Bay Area NET Conference. (MORE)
| |
| We are pleased to announce that this eUpdate
is sponsored by Novartis Pharmaceutical Corporation.
| |
|
|
|
|
